Ilomastat

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIlomastat
Drug Alias NameGalardinCS-610GM-6001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsCorneal Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals IncUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLigand Pharmaceuticals IncArriva PharmaceuticalsQuick-Med Technologies +[4] 
Active IndicationsN/A
Inactive IndicationsCorneal Ulcer

Other Information

ATC CodeN/A
Related LinksN/A